相似文献
1
Characteristics of Emergency Department Patients With COVID-19 at a Single Site in Northern California: Clinical Observations and Public Health Implications.加利福尼亚州北部某单一地点的急诊科新冠患者特征：临床观察与公共卫生影响
Acad Emerg Med. 2020 Jun;27(6):505-509. doi: 10.1111/acem.14003. Epub 2020 May 15.
2
Characteristics and Outcomes of Coronavirus Disease Patients under Nonsurge Conditions, Northern California, USA, March-April 2020.2020 年 3 月至 4 月，美国北加州非紧急状况下的冠状病毒疾病患者的特征和结局。
Emerg Infect Dis. 2020 Aug;26(8):1679-1685. doi: 10.3201/eid2608.201776. Epub 2020 May 14.
3
Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California.加利福尼亚州综合医疗保健系统中 COVID-19 住院成人的特征。
JAMA. 2020 Jun 2;323(21):2195-2198. doi: 10.1001/jama.2020.7202.
4
Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19.COVID-19 住院和非住院患者中哮喘的患病率和特征。
J Allergy Clin Immunol. 2020 Aug;146(2):307-314.e4. doi: 10.1016/j.jaci.2020.06.010. Epub 2020 Jun 15.
5
Comorbidities and Mortality in Patients With COVID-19 Aged 60 Years and Older in a University Hospital in Spain.西班牙一家大学医院中60岁及以上新冠病毒疾病患者的合并症与死亡率
Arch Bronconeumol (Engl Ed). 2020 Nov;56(11):756-758. doi: 10.1016/j.arbres.2020.06.012. Epub 2020 Jul 16.
6
How deadly is the coronavirus? Scientists are close to an answer.新冠病毒有多致命？科学家们即将找到答案。
Nature. 2020 Jun;582(7813):467-468. doi: 10.1038/d41586-020-01738-2.
7
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.意大利新冠肺炎死亡患者的病死率及特征
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.
8
Clinical characteristics and risk factors for mortality of patients with COVID-19 in a large data set from Mexico.墨西哥大型数据集内 COVID-19 患者的临床特征和死亡风险因素。
Ann Epidemiol. 2020 Dec;52:93-98.e2. doi: 10.1016/j.annepidem.2020.08.005. Epub 2020 Aug 14.
9
10
Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.预测因 SARS-CoV-2 导致的死亡率：一个将肥胖和糖尿病与墨西哥 COVID-19 结局相关联的机制评分。
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa346.
引用本文的文献
1
Asthma and COPD as co-morbidities in patients hospitalised with Covid-19 disease: a global systematic review and meta-analysis.哮喘和 COPD 作为与 COVID-19 疾病住院患者共病的研究：全球系统回顾和荟萃分析。
BMC Pulm Med. 2023 Nov 22;23(1):462. doi: 10.1186/s12890-023-02761-5.
2
Global prevalence and effect of comorbidities and smoking status on severity and mortality of COVID-19 in association with age and gender: a systematic review, meta-analysis and meta-regression.全球范围内，与年龄和性别相关的 COVID-19 严重程度和死亡率与合并症和吸烟状况的关系：系统评价、荟萃分析和荟萃回归。
Sci Rep. 2023 Apr 19;13(1):6415. doi: 10.1038/s41598-023-33314-9.
3
The association of the COVID-19 outbreak with in-hospital mortality: A single-centre study from Indonesia.新型冠状病毒肺炎疫情与院内死亡率的关联：一项来自印度尼西亚的单中心研究。
Clin Epidemiol Glob Health. 2023 Mar-Apr;20:101219. doi: 10.1016/j.cegh.2023.101219. Epub 2023 Feb 4.
4
Effects of SARS-CoV-2 infections in patients with cancer on mortality, ICU admission and incidence: a systematic review with meta-analysis involving 709,908 participants and 31,732 cancer patients.SARS-CoV-2 感染对癌症患者死亡率、入住 ICU 率和发病率的影响：一项涉及 709908 名参与者和 31732 例癌症患者的系统评价和荟萃分析。
J Cancer Res Clin Oncol. 2023 Jul;149(7):2915-2928. doi: 10.1007/s00432-022-04191-y. Epub 2022 Jul 13.
5
Impact of diabetes on COVID-19 mortality and hospital outcomes from a global perspective: An umbrella systematic review and meta-analysis.从全球视角看糖尿病对 COVID-19 死亡率和医院转归的影响：伞式系统评价和荟萃分析。
Endocrinol Diabetes Metab. 2022 May;5(3):e00338. doi: 10.1002/edm2.338. Epub 2022 Apr 20.
6
Impact of cancer diagnoses on the outcomes of patients with COVID-19: a systematic review and meta-analysis.癌症诊断对 COVID-19 患者结局的影响：系统评价和荟萃分析。
BMJ Open. 2022 Feb 7;12(2):e044661. doi: 10.1136/bmjopen-2020-044661.
7
Effect modification of the association between comorbidities and severe course of COVID-19 disease by age of study participants: a systematic review and meta-analysis.合并症与 COVID-19 疾病严重程度相关性的年龄效应修饰作用：系统评价和荟萃分析。
Syst Rev. 2021 Jun 30;10(1):194. doi: 10.1186/s13643-021-01732-3.
8
Prevalence and prognosis of otorhinolaryngological symptoms in patients with COVID-19: a systematic review and meta-analysis.COVID-19 患者耳鼻喉症状的患病率和预后：系统评价和荟萃分析。
Eur Arch Otorhinolaryngol. 2022 Jan;279(1):49-60. doi: 10.1007/s00405-021-06900-8. Epub 2021 May 25.
9
Who Stayed Home Under Safer-at-Home? Impacts of COVID-19 on Volume and Patient-Mix at an Emergency Department.谁在“居家安全”政策下待在家中？COVID-19 对急诊科就诊量和患者构成的影响。
West J Emerg Med. 2021 Feb 8;22(2):234-243. doi: 10.5811/westjem.2020.12.49234.
10
Effect of the COVID-19 pandemic lockdown on non-COVID-19 emergency department visits in Eastern France: Reduced risk or avoidance behavior?新冠疫情封锁对法国东部非新冠急诊就诊的影响：风险降低还是规避行为？
Public Health Pract (Oxf). 2021 Nov;2:100109. doi: 10.1016/j.puhip.2021.100109. Epub 2021 Mar 27.
本文引用的文献
1
Triplex Real-Time RT-PCR for Severe Acute Respiratory Syndrome Coronavirus 2.三重实时 RT-PCR 检测严重急性呼吸综合征冠状病毒 2 型。
Emerg Infect Dis. 2020 Jul;26(7):1633-1635. doi: 10.3201/eid2607.201285. Epub 2020 Jun 21.
2
Rates of Co-infection Between SARS-CoV-2 and Other Respiratory Pathogens.SARS-CoV-2 与其他呼吸道病原体的合并感染率。
JAMA. 2020 May 26;323(20):2085-2086. doi: 10.1001/jama.2020.6266.
3
Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China.从中国武汉的传播动态估计 COVID-19 的临床严重程度。
Nat Med. 2020 Apr;26(4):506-510. doi: 10.1038/s41591-020-0822-7. Epub 2020 Mar 19.
4
Association of Public Health Interventions With the Epidemiology of the COVID-19 Outbreak in Wuhan, China.公共卫生干预措施与中国武汉 COVID-19 疫情流行病学的关联。
JAMA. 2020 May 19;323(19):1915-1923. doi: 10.1001/jama.2020.6130.
5
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
6
An interactive web-based dashboard to track COVID-19 in real time.一个基于网络的交互式仪表盘，用于实时追踪新冠病毒。
Lancet Infect Dis. 2020 May;20(5):533-534. doi: 10.1016/S1473-3099(20)30120-1. Epub 2020 Feb 19.
Zotero 插件